Feasibility of fractionating MAG3 ™ cold kit for cost reduction

Nuclear Medicine Communications

Volumn 13, Issue 11, 1992, Pages 832-837

  Thorson, L M ^a   Hung, J C ^a   Hollar, B S ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MERTIATIDE TC 99M; RADIOPHARMACEUTICAL AGENT; TECHNESCAN MAG3; TECHNETIUM 99M; UNCLASSIFIED DRUG;

ARTICLE; COST EFFECTIVENESS ANALYSIS; DRUG DOSE; DRUG PURITY; DRUG STORAGE; RADIOCHEMISTRY;

COSTS AND COST ANALYSIS; FEASIBILITY STUDIES; RADIONUCLIDE GENERATORS; TECHNETIUM TC 99M MERTIATIDE;

EID: 0026441084     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-199211000-00010     Document Type: Article

References (8)

1. Lerthirunwong C, Cheng KT, Hladik WB. A study of the concept of unit dosing reagent kits: an efficient and cost- saving method for dispensing radiopharmaceuticals. J Nucl Med Technol 1988; 20: 173 (abs).
2. 99mTc]HM-PAO. J Nucl Med 1990; 31: 127-8 (letter).
3. Ballinger J. Preparation of technetium-99m-HMPAO. J Nucl Med 1990; 31: 1892 (letter).
4. Cheng KT, Brown BM, Sheppard MS, Xue F-P. A study of the preparation of disofenin and gluceptate cold-unit doses. J Nucl Med Technol 1992; 20: 33-5.
5. Datasheet/directions for use of TechneScan® MAG3. Mallinckrodt Medical BV, Petten, The Netherlands, 4 November, 1991.
6. Technical product data of TechneScan MAG3™, R6/90. Mallinckrodt Medical, Inc., St Louis, MO, USA.
7. Kowalsky RJ, Dalton DR. Technical problems associated with the production of technetium Tc99m tin(II) pyrophosphate kits. Am J Hosp Pharm 1981; 38: 1722-6.
8. Hung JC, Thorson LM, Hollar BS. Feasibility of fractionating MAG3™ cold kit for cost reduction. Nucl Med Commun 1992; 13: 230 (abs).